Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence
Open Access
- 29 August 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging
- Vol. 5, 1448543
Abstract
Cellular senescence is a diverse phenotype characterised by permanent cell cycle arrest and an associated secretory phenotype (SASP) which includes inflammatory cytokines. Typically, senescent cells are removed by the immune system, but this process becomes dysregulated with age causing senescent cells to accumulate and induce chronic inflammatory signalling. Identifying senescent cells is challenging due to senescence phenotype heterogeneity, and senotherapy often requires a combinatorial approach. Here we systematically collected 119 transcriptomic datasets related to human fibroblasts, forming an online database describing the relevant variables for each study allowing users to filter for variables and genes of interest. Our own analysis of the database identified 28 genes significantly up- or downregulated across four senescence types (DNA damage induced senescence (DDIS), oncogene induced senescence (OIS), replicative senescence, and bystander induced senescence) compared to proliferating controls. We also found gene expression patterns of conventional senescence markers were highly specific and reliable for different senescence inducers, cell lines, and timepoints. Our comprehensive data supported several observations made in existing studies using single datasets, including stronger p53 signalling in DDIS compared to OIS. However, contrary to some early observations, both p16 and p21 mRNA levels rise quickly, depending on senescence type, and persist for at least 8–11 days. Additionally, little evidence was found to support an initial TGFβ-centric SASP. To support our transcriptomic analysis, we computationally modelled temporal protein changes of select core senescence proteins during DDIS and OIS, as well as perform knockdown interventions. We conclude that while universal biomarkers of senescence are difficult to identify, conventional senescence markers follow predictable profiles and construction of a framework for studying senescence could lead to more reproducible data and understanding of senescence heterogeneity.Keywords
This publication has 200 references indexed in Scilit:
- Dissecting primary and secondary senescence to enable new senotherapeutic strategiesAgeing Research Reviews, 2021
- Quantitative Proteomic Analysis of the Senescence‐Associated Secretory Phenotype by Data‐Independent AcquisitionCurrent Protocols, 2021
- Unscheduled HDAC4 repressive activity in human fibroblasts triggers TP53‐dependent senescence and favors cell transformationMolecular Oncology, 2018
- Tellurium: An extensible python-based modeling environment for systems and synthetic biologyBioSystems, 2018
- PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent CellsCancer Cell, 2018
- A comparison of oncogene-induced senescence and replicative senescence: implications for tumor suppression and agingAGE, 2014
- Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular SenescenceCancer Cell, 2010
- p53 and the Li-Fraumeni syndromeCancer Genetics and Cytogenetics, 1993
- mdm2 expression is induced by wild type p53 activity.The EMBO Journal, 1993
- A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaCell, 1992